Selinexor and dexamethasone in multiple myeloma
Selinexor and dexamethasone in multiple myeloma
About this item
Full title
Author / Creator
Publisher
England: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
In the study, Dan Vogl (Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA) and colleagues enrolled 79 patients with multiple myeloma refractory to bortezomib, carfilzomib, lenalidomide, and pomalidomide. 31 of these patients had disease that was also refractory to an anti-CD38 antibody.“Patients require a lot of support...
Alternative Titles
Full title
Selinexor and dexamethasone in multiple myeloma
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2001403502
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2001403502
Other Identifiers
ISSN
1470-2045
E-ISSN
1474-5488
DOI
10.1016/S1470-2045(18)30089-5
